🔥36氪•Stalecollected in 30m
CCTV Investigates Massive Price Discrepancy in Centralized Drug Procurement
#healthcare-ai#compliance#data-monitoringmalaysian-avarcitinib-tabletscctvnational-healthcare-security-administration
💡Learn how AI-powered data monitoring can solve critical compliance and pricing transparency issues in the healthcare sec
⚡ 30-Second TL;DR
What Changed
Centralized procurement drug 'Malaysian Avarcitinib' (Qing'anxin) shows a 40x price difference.
Why It Matters
This highlights the need for AI-driven price monitoring and automated compliance auditing in the pharmaceutical supply chain to prevent price gouging.
What To Do Next
If building healthcare tech, implement automated web scraping and anomaly detection algorithms to monitor drug pricing compliance across e-commerce platforms.
Who should care:Developers & AI Engineers
Key Points
- •Centralized procurement drug 'Malaysian Avarcitinib' (Qing'anxin) shows a 40x price difference.
- •Standard price is around 100 RMB, but some pharmacies list it at 3960 RMB.
- •National Healthcare Security Administration's online comparison tool confirms high-price listings persist.
📰
Weekly AI Recap
Read this week's curated digest of top AI events →
👉Related Updates
AI-curated news aggregator. All content rights belong to original publishers.
Original source: 36氪 ↗